SE7800902L - Blodfraktionsframstellning - Google Patents

Blodfraktionsframstellning

Info

Publication number
SE7800902L
SE7800902L SE7800902A SE7800902A SE7800902L SE 7800902 L SE7800902 L SE 7800902L SE 7800902 A SE7800902 A SE 7800902A SE 7800902 A SE7800902 A SE 7800902A SE 7800902 L SE7800902 L SE 7800902L
Authority
SE
Sweden
Prior art keywords
blood
plasma
blood fraction
dithiothreitol
fraction preparation
Prior art date
Application number
SE7800902A
Other languages
English (en)
Other versions
SE443293B (sv
Original Assignee
Blombaeck E G B
Hessel Dagny Birgitta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blombaeck E G B, Hessel Dagny Birgitta filed Critical Blombaeck E G B
Priority to SE7800902A priority Critical patent/SE443293B/sv
Priority to US06/005,877 priority patent/US4229435A/en
Priority to DE19792902657 priority patent/DE2902657A1/de
Publication of SE7800902L publication Critical patent/SE7800902L/sv
Publication of SE443293B publication Critical patent/SE443293B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7800902A 1978-01-25 1978-01-25 Blodfraktionsframstellning SE443293B (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE7800902A SE443293B (sv) 1978-01-25 1978-01-25 Blodfraktionsframstellning
US06/005,877 US4229435A (en) 1978-01-25 1979-01-23 Preparation of blood fraction
DE19792902657 DE2902657A1 (de) 1978-01-25 1979-01-24 Verfahren zur herstellung von den gerinnungsfaktor ii, v oder viii oder deren gemische enthaltenden konzentraten oder von den faktoren vii, ix, x, xi oder xii oder den gemischen freiem plasma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7800902A SE443293B (sv) 1978-01-25 1978-01-25 Blodfraktionsframstellning

Publications (2)

Publication Number Publication Date
SE7800902L true SE7800902L (sv) 1979-07-26
SE443293B SE443293B (sv) 1986-02-24

Family

ID=20333761

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7800902A SE443293B (sv) 1978-01-25 1978-01-25 Blodfraktionsframstellning

Country Status (3)

Country Link
US (1) US4229435A (sv)
DE (1) DE2902657A1 (sv)
SE (1) SE443293B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982004395A1 (en) * 1981-06-18 1982-12-23 Erik Gustaf Birger Blombaeck A process in purification and concentration of the factor viii complex
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
DE4439480C1 (de) * 1994-11-08 1996-06-05 Asta Medica Ag Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate
US6586573B1 (en) 1999-02-22 2003-07-01 Baxter International Inc. Albumin-free Factor VIII formulations
US20070015911A1 (en) * 2005-03-31 2007-01-18 Warder Scott E Methods for biomarker discovery and diagnostic screening
AU2009313325B2 (en) * 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates

Also Published As

Publication number Publication date
SE443293B (sv) 1986-02-24
DE2902657A1 (de) 1979-07-26
US4229435A (en) 1980-10-21

Similar Documents

Publication Publication Date Title
BE861003A (fr) Phenyle substitue-prop(en)yl-amines et leurs n-oxydes, agents fongicides les contenant, ainsi que procede de preparation
ES8105746A1 (es) Procedimiento para producir el compuesto (n-fosfonacetil-l- aspartato) (1,2-diaminociclohexano) platino (ii).
BG37375A3 (en) Method for preparing prolinic derivatives
RO77732A (ro) Procedeu pentru prepararea unor derivati de fenetanolamina
IT1062511B (it) Metodo e composizione per rimuovere il virus dell'epatite da materiali biologici
SE7800902L (sv) Blodfraktionsframstellning
FR2346332A1 (fr) Nouveaux derives de prostaglandine, leur procede de preparation ainsi que les compositions therapeutiques les contenant
RO78491A (ro) Procedeu pentru prepararea unor derivati ai 2-amino-pirimidonelor
SE415035B (sv) Framstellning av urokinas ur en kultur av levande njurceller odlade i nervaro av glycin
FR2362598A1 (fr) Succedane du tabac revetu de poussiere de tabac
SE7907986L (sv) Sett att framstella 3alfa,7beta-dihydroxicholansyra
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
RO81936A (ro) Procedeu pentru prepararea unor derivati ai acidului 7 beta-aminotiazolilacetamido-3-cefem-4-carboxilic
IT1164040B (it) Derivati acetilenici dell'androsi-4-ene,procedimento per la loro produzione,loro impiego come medicamenti e composizioni farmaceutiche che li contengono
ES486749A1 (es) Procedimiento para la preparacion de amidas de acidos isoxa-zol-4-carboxilicos
FR2322544A1 (fr) Degagement de l'ethylene dans les plantes, par un melange ameliore contenant de l'acide 2-chloro-ethylphosphonique
LU79157A1 (fr) Procede de preparation de nouveaux derives de l'oxadiazole-1,3,4 et de compositions fongicides les contenant
FR2591591B1 (fr) Alkylcarboxamides de pyridylalkylamines, leurs preparations et leur utilisation en tant que medicaments
NL7603461A (nl) D-homosteroiden en werkwijze voor de bereiding daarvan.
BE848666A (fr) Production d'acide citrique dans des mileux de fermentation a base de paraffine non deshuilee,
AR228239A1 (es) Nuevos derivados insaturados de(3,5-dicloro-2-piridiloxi)fenoxi
SU700558A1 (ru) Цементуема высокопрочна сталь
SE7708919L (sv) Kopparlegering
BE839761A (fr) Nouveaux derives de prostaglandine, leur procede de preparation ainsi que les compositions therapeutiques les contenant
BE849431A (fr) Nouveaux derives de decahydroquinoleine, leurs preparations de preparation ainsi que les compositions therapeutiques les contenant

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7800902-4

Effective date: 19880915

Format of ref document f/p: F